State TX
Clinical Trials in Texas
Recruiting clinical trials with at least one study location in Texas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Texas
NCT06575192 Phase 3
Recruiting
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix...
Condition
Breast Reconstruction
Enrollment
783 pts
Location
United States
Sponsor
AbbVie
NCT06079671 Phase 3
Recruiting
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (e...
Condition
Locally Advanced Cervical Cancer
Enrollment
800 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
NCT06806592 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to ...
Condition
Interstitial Lung Diseases
Enrollment
400 pts
Location
United States, Australia, Austria
Sponsor
Boehringer Ingelheim
NCT06137144 Phase 1, Phase 2
Recruiting
AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants...
Condition
Lymphoma
Enrollment
110 pts
Location
United States, Australia, France
Sponsor
AstraZeneca
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07400588 Phase 2
Recruiting
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus
Condition
Obese
Enrollment
50 pts
Location
United States
Sponsor
Gasherbrum Bio, Inc., a wholly
NCT05846802 N/A
Recruiting
Gastroparesis Registry 4
Condition
Gastroparesis
Enrollment
250 pts
Location
United States
Sponsor
Johns Hopkins Bloomberg School
NCT06823167 Phase 1
Recruiting
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Condition
Solid Malignancies
Enrollment
117 pts
Location
United States, Spain
Sponsor
Immunome, Inc.
NCT03128879 Phase 2
Recruiting
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
Condition
Chronic Lymphocytic Leukemia
Enrollment
90 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06995729 Phase 1
Recruiting
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Chi...
Condition
Acute Treatment of Migraine
Enrollment
16 pts
Location
United States
Sponsor
Pfizer
NCT04196257 Phase 1
Recruiting
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Condition
Solid Tumor, Adult
Enrollment
50 pts
Location
United States
Sponsor
Bio-Path Holdings, Inc.
NCT07175428 Phase 2
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Antic...
Condition
Atrial Fibrillation (AF)
Enrollment
1,200 pts
Location
United States, Canada
Sponsor
Regeneron Pharmaceuticals
NCT06533059 Phase 1
Recruiting
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant S...
Condition
Cancer
Enrollment
110 pts
Location
United States, Australia, France
Sponsor
Alterome Therapeutics, Inc.
NCT06937229 Phase 3
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agi...
Condition
Alzheimer Disease
Enrollment
600 pts
Location
United States, Argentina, Brazil
Sponsor
Bristol-Myers Squibb
NCT06106672 Phase 1, Phase 2
Recruiting
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in S...
Condition
Myasthenia Gravis
Enrollment
54 pts
Location
United States
Sponsor
COUR Pharmaceutical Developmen
NCT06903819 Phase 4
Recruiting
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
Condition
Orthopedic Trauma Surgery Patients
Enrollment
90 pts
Location
United States
Sponsor
Texas Tech University Health S
NCT04559230 Phase 2
Recruiting
Sacituzumab Govitecan in Recurrent Glioblastoma
Condition
Recurrent Glioblastoma
Enrollment
32 pts
Location
United States
Sponsor
The University of Texas Health
NCT03339128 Phase 2
Recruiting
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bow...
Condition
Irritable Bowel Syndrome
Enrollment
95 pts
Location
United States, Bulgaria, Canada
Sponsor
AbbVie
NCT05693701 N/A
Recruiting
Multicomponent Intervention Study- Blood Donors With High Cholesterol
Condition
Lipid Metabolism Disorder
Enrollment
100 pts
Location
United States
Sponsor
University of Texas Southweste
NCT07027111 Phase 2
Recruiting
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDP
Condition
Chronic Inflammatory Demyelinating Polyneuropathy
Enrollment
60 pts
Location
United States
Sponsor
Nuvig Therapeutics, Inc.
NCT07431853 Phase 2
Recruiting
A Study to Learn About mRNA Vaccines Against Influenza in Adults
Condition
Healthy Adults
Enrollment
770 pts
Location
United States
Sponsor
Pfizer
NCT06792695 Phase 2
Recruiting
A Study of Novel Study Interventions and Combinations in Participants With Color...
Condition
Metastatic Colorectal Cancer
Enrollment
120 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT06508801 N/A
Recruiting
Blood Flow Restriction for Optimizing Balance in Parkinson's Disease
Condition
Parkinson's Disease and Parkinsonism
Enrollment
20 pts
Location
United States
Sponsor
The University of Texas Health
NCT01492036 N/A
Recruiting
Long-Term Follow-Up of Recipient of Gene Transfer Research
Condition
Retroviridae Infections
Enrollment
130 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05079711 N/A
Recruiting
Comparative Performance of a Vaginal Yeast Test
Condition
Vulvovaginal Candidiasis
Enrollment
1,200 pts
Location
United States, Germany
Sponsor
Uniformed Services University